Pegasystems Q4 Results: Analysts Optimisticby Lilu Anderson 12.02.2024Pegasystems is expected to announce strong fourth-quarter results, supported by stable spending and ongoing digital transformation initiatives. Analysts believe in ...
Take-Two Stock: Wolfe Cuts Price with GTA Delaysby Mark Eisenberg 12.02.2024Take-Two Interactive's price target is adjusted to $180 by Wolfe Research, citing strong performance and potential for earnings growth.
Investcorp Plans Gulf Listing by 2024: Analyst Analysisby Mark Eisenberg 12.02.2024Investment company Investcorp plans to list a portfolio company in the Gulf region by 2024, with optimism for completion in ...
Babcock & Wilcox Lands $13M Refinery Contractby Terry Bingman 12.02.2024Babcock & Wilcox secures $13 million contract to provide environmental equipment to a North American petroleum refinery. The deal includes ...
Joby Aviation Stock Surges after Securing Dubai Taxi Dealby Mark Eisenberg 12.02.2024Joby Aviation stock rises 4.2% as company secures exclusive deal for air taxi services in Dubai, positioning them as a ...
Maximizing Employee Stock Options: Insider Strategiesby Mark Eisenberg 12.02.2024Learn how to maximize the value of your employee stock options (ESOs) with strategies, tips, and long-term planning. A comprehensive ...
Evercore Stands By FIS Amid Market Pressuresby Mark Eisenberg 12.02.2024Evercore ISI maintains "In Line" rating on Fidelity National Information Services (FIS) despite challenges in its Banking Solutions and Capital ...
S&P 500 Hits Historic 5000: What’s Next?by Mark Eisenberg 12.02.2024The S&P 500 has reached a historic milestone, surpassing 5000 points for the first time and doubling since the pandemic ...
Sigma Lithium Gains Approval for $100M Expansion from BNDESby Mark Eisenberg 12.02.2024Sigma Lithium has received preliminary financing approval from the Development Bank of Brazil for its expansion project, allowing the company ...
Atossa Genetics: Potential Breakthrough in Breast Cancer?by Lilu Anderson 12.02.2024Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...